Free Trial

Arteris (NASDAQ:AIP) CEO Sells $1,310,000.00 in Stock

Arteris logo with Computer and Technology background

Key Points

  • Arteris CEO K Charles Janac sold 100,000 shares of the company's stock for a total of $1,310,000, reducing his ownership to approximately 9.74 million shares.
  • Following the sale, the company's stock saw a 4.2% increase in trading, reaching $13.49 with a market capitalization of $575.35 million.
  • Wall Street analysts have varied opinions on Arteris, with the consensus rating being a "Moderate Buy" and an average target price of $15.00.
  • Five stocks we like better than Arteris.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 100,000 shares of the company's stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $13.10, for a total value of $1,310,000.00. Following the sale, the chief executive officer owned 9,739,071 shares in the company, valued at approximately $127,581,830.10. This trade represents a 1.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

K Charles Janac also recently made the following trade(s):

  • On Monday, October 6th, K Charles Janac sold 5,755 shares of Arteris stock. The stock was sold at an average price of $14.00, for a total value of $80,570.00.
  • On Friday, October 3rd, K Charles Janac sold 11,821 shares of Arteris stock. The stock was sold at an average price of $11.07, for a total value of $130,858.47.
  • On Thursday, October 2nd, K Charles Janac sold 7,147 shares of Arteris stock. The stock was sold at an average price of $10.92, for a total value of $78,045.24.
  • On Thursday, September 4th, K Charles Janac sold 2,057 shares of Arteris stock. The stock was sold at an average price of $8.73, for a total value of $17,957.61.
  • On Tuesday, September 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The stock was sold at an average price of $8.94, for a total value of $11,139.24.
  • On Tuesday, August 5th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.12, for a total value of $656,000.00.
  • On Tuesday, August 5th, K Charles Janac sold 94,245 shares of Arteris stock. The shares were sold at an average price of $13.49, for a total value of $1,271,365.05.

Arteris Trading Up 4.2%

Shares of NASDAQ:AIP traded up $0.54 during trading on Wednesday, reaching $13.49. The stock had a trading volume of 816,598 shares, compared to its average volume of 570,721. Arteris, Inc. has a one year low of $5.46 and a one year high of $14.58. The company has a market capitalization of $575.35 million, a P/E ratio of -16.45 and a beta of 1.45. The firm's 50-day simple moving average is $9.78 and its 200 day simple moving average is $8.50.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.11). Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. The business had revenue of $16.50 million for the quarter, compared to analysts' expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on AIP shares. Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a research report on Monday, September 15th. TD Cowen raised their price objective on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a research report on Wednesday. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Arteris presently has a consensus rating of "Moderate Buy" and an average target price of $15.00.

Check Out Our Latest Stock Report on AIP

Hedge Funds Weigh In On Arteris

Institutional investors and hedge funds have recently modified their holdings of the stock. Cambridge Investment Research Advisors Inc. acquired a new position in shares of Arteris in the 1st quarter valued at about $95,000. Acadian Asset Management LLC lifted its holdings in shares of Arteris by 40.6% in the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after buying an additional 260,277 shares during the period. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Arteris by 48.5% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 249,517 shares of the company's stock valued at $1,724,000 after buying an additional 81,516 shares during the period. Nuveen LLC acquired a new position in shares of Arteris in the 1st quarter valued at about $349,000. Finally, Public Employees Retirement System of Ohio acquired a new position in shares of Arteris in the 2nd quarter valued at about $203,000. Institutional investors and hedge funds own 64.36% of the company's stock.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.